186 related articles for article (PubMed ID: 28987837)
1. Physiologic Growth Hormone-Replacement Therapy and Craniopharyngioma Recurrence in Pediatric Patients: A Meta-Analysis.
Alotaibi NM; Noormohamed N; Cote DJ; Alharthi S; Doucette J; Zaidi HA; Mekary RA; Smith TR
World Neurosurg; 2018 Jan; 109():487-496.e1. PubMed ID: 28987837
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone therapy and risk of recurrence/progression in intracranial tumors: a meta-analysis.
Shen L; Sun CM; Li XT; Liu CJ; Zhou YX
Neurol Sci; 2015 Oct; 36(10):1859-67. PubMed ID: 26048536
[TBL] [Abstract][Full Text] [Related]
3. Physiological growth hormone replacement and rate of recurrence of craniopharyngioma: the Genentech National Cooperative Growth Study.
Smith TR; Cote DJ; Jane JA; Laws ER
J Neurosurg Pediatr; 2016 Oct; 18(4):408-412. PubMed ID: 27286443
[TBL] [Abstract][Full Text] [Related]
4. Safety of Growth Hormone Replacement Therapy in Childhood-Onset Craniopharyngioma: A Systematic Review and Cohort Study.
van Schaik J; Kormelink E; Kabak E; van Dalen EC; Schouten-van Meeteren AYN; de Vos-Kerkhof E; Bakker B; Fiocco M; Hoving EW; Tissing WJE; van Santen HM
Neuroendocrinology; 2023; 113(10):987-1007. PubMed ID: 37231961
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone replacement therapy reduces risk of cancer in adult with growth hormone deficiency: A meta-analysis.
Li Z; Zhou Q; Li Y; Fu J; Huang X; Shen L
Oncotarget; 2016 Dec; 7(49):81862-81869. PubMed ID: 27835910
[TBL] [Abstract][Full Text] [Related]
6. Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up.
Olsson DS; Buchfelder M; Wiendieck K; Kremenevskaja N; Bengtsson BÅ; Jakobsson KE; Jarfelt M; Johannsson G; Nilsson AG
Eur J Endocrinol; 2012 Jun; 166(6):1061-8. PubMed ID: 22457235
[TBL] [Abstract][Full Text] [Related]
7. GH and Childhood-onset Craniopharyngioma: When to Initiate GH Replacement Therapy?
Nguyen Quoc A; Beccaria K; González Briceño L; Pinto G; Samara-Boustani D; Stoupa A; Beltrand J; Besançon A; Thalassinos C; Puget S; Blauwblomme T; Alapetite C; Bolle S; Doz F; Grill J; Dufour C; Bourdeaut F; Abbou S; Guerrini-Rousseau L; Leruste A; Brabant S; Cavadias I; Viaud M; Boddaert N; Polak M; Kariyawasam D
J Clin Endocrinol Metab; 2023 Jul; 108(8):1929-1936. PubMed ID: 36794424
[TBL] [Abstract][Full Text] [Related]
8. Growth Hormone Therapy Does Not Increase the Risk of Craniopharyngioma and Nonfunctioning Pituitary Adenoma Recurrence.
Losa M; Castellino L; Pagnano A; Rossini A; Mortini P; Lanzi R
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32112101
[TBL] [Abstract][Full Text] [Related]
9. Rapid enlargement of a residual craniopharyngioma during short-term growth hormone replacement.
Caldarelli M; Borrelli P
Childs Nerv Syst; 2002 Nov; 18(11):567. PubMed ID: 12530355
[No Abstract] [Full Text] [Related]
10. Benefits and risks evaluation of recombinant human growth hormone replacement therapy in children with GHD after craniopharyngioma surgery.
Pei LL; Guo Y; Chen H; Zhong LY
J Pediatr Endocrinol Metab; 2023 May; 36(5):484-491. PubMed ID: 36935568
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor control.
Packer RJ; Boyett JM; Janss AJ; Stavrou T; Kun L; Wisoff J; Russo C; Geyer R; Phillips P; Kieran M; Greenberg M; Goldman S; Hyder D; Heideman R; Jones-Wallace D; August GP; Smith SH; Moshang T
J Clin Oncol; 2001 Jan; 19(2):480-7. PubMed ID: 11208842
[TBL] [Abstract][Full Text] [Related]
12. Long-term safety of growth hormone replacement after CNS irradiation.
Mackenzie S; Craven T; Gattamaneni HR; Swindell R; Shalet SM; Brabant G
J Clin Endocrinol Metab; 2011 Sep; 96(9):2756-61. PubMed ID: 21715535
[TBL] [Abstract][Full Text] [Related]
13. Rapid enlargement of a residual craniopharyngioma during short-term growth hormone replacement.
Hayward R
Childs Nerv Syst; 2002 Nov; 18(11):565; author reply 566. PubMed ID: 12420115
[No Abstract] [Full Text] [Related]
14. Growth hormone treatment and risk of recurrence or development of secondary neoplasms in survivors of pediatric brain tumors.
Wang ZF; Chen HL
J Clin Neurosci; 2014 Dec; 21(12):2155-9. PubMed ID: 25065848
[TBL] [Abstract][Full Text] [Related]
15. Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy.
Olsson DS; Buchfelder M; Schlaffer S; Bengtsson BA; Jakobsson KE; Johannsson G; Nilsson AG
Eur J Endocrinol; 2009 Nov; 161(5):663-9. PubMed ID: 19734242
[TBL] [Abstract][Full Text] [Related]
16. The effect of growth hormone replacement in patients with hypopituitarism on pituitary tumor recurrence, secondary cancer, and stroke.
Jasim S; Alahdab F; Ahmed AT; Tamhane SU; Sharma A; Donegan D; Nippoldt TB; Murad MH
Endocrine; 2017 May; 56(2):267-278. PubMed ID: 27815769
[TBL] [Abstract][Full Text] [Related]
17. Postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement in patients with childhood-onset craniopharyngioma.
Miao Y; Fan K; Peng X; Li S; Chen J; Bai RN; Wei Y; Deng Y; Zhao C; Wu Q; Ge M; Gong J; Wu D
Front Endocrinol (Lausanne); 2023; 14():1241145. PubMed ID: 38027203
[TBL] [Abstract][Full Text] [Related]
18. Postoperative pituitary hormonal disturbances and hormone replacement therapy time and dosage in children with craniopharyngiomas.
Li GM; Sun XJ; Shao P
Chin Med J (Engl); 2008 Oct; 121(20):2077-82. PubMed ID: 19080279
[TBL] [Abstract][Full Text] [Related]
19. Analyses of treatment variables for patients with childhood craniopharyngioma--results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up.
Müller HL; Gebhardt U; Schröder S; Pohl F; Kortmann RD; Faldum A; Zwiener I; Warmuth-Metz M; Pietsch T; Calaminus G; Kolb R; Wiegand C; Sörensen N;
Horm Res Paediatr; 2010; 73(3):175-80. PubMed ID: 20197669
[TBL] [Abstract][Full Text] [Related]
20. Surgical treatment of ectopic recurrence of craniopharyngioma. Report of 4 cases.
Elliott RE; Moshel YA; Wisoff JH
J Neurosurg Pediatr; 2009 Aug; 4(2):105-12. PubMed ID: 19645541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
